Quantbot Technologies’s Edwards Lifesciences EW Stock Holding History

Quantbot Technologies’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,720	Closed	-$1.6M	–	1832
2025 Q4	$1.6M	Buy	+18,720	New	+$1.54M	0.05%	526
2025 Q2	–	Sell	-362	Closed	-$26.2K	–	1709
2025 Q1	$26.2K	Buy	+362	New	+$25.9K	﹤0.01%	1367
2024 Q4	–	Sell	-206,625	Closed	-$13.6M	–	1580
2024 Q3	$13.6M	Buy	+206,625	New	+$15M	0.54%	10
2024 Q1	–	Sell	-23,803	Closed	-$1.81M	–	1658
2023 Q4	$1.81M	Sell	23,803 -91,351	-79%	-$6.36M	0.11%	307
2023 Q3	$7.98M	Buy	115,154 +107,441	+1,393%	+$8.63M	0.54%	21
2023 Q2	$728K	Buy	7,713 +413	+6%	+$35.9K	0.05%	535
2023 Q1	$604K	Sell	7,300 -62,708	-90%	-$4.93M	0.04%	557
2022 Q4	$5.22M	Sell	70,008 -8,412	-11%	-$648K	0.37%	38
2022 Q3	$6.48M	Buy	78,420 +68,508	+691%	+$6.59M	0.49%	12
2022 Q2	$942K	Buy	9,912 +3,699	+60%	+$383K	0.09%	347
2022 Q1	$731K	Buy	+6,213	New	+$697K	0.06%	444
2021 Q4	–	Sell	-47,033	Closed	-$5.32M	–	1634
2021 Q3	$5.32M	Buy	+47,033	New	+$5.37M	0.39%	50
2020 Q4	–	Sell	-61,564	Closed	-$4.91M	–	1397
2020 Q3	$4.91M	Sell	61,564 -1,917	-3%	-$150K	0.56%	29
2020 Q2	$4.39M	Buy	63,481 +52,627	+485%	+$3.74M	0.58%	45
2020 Q1	$682K	Sell	10,854 -74,109	-87%	-$5.34M	0.44%	59
2019 Q4	$6.61M	Buy	+84,963	New	+$6.63M	0.66%	23
2019 Q3	–	Sell	-34,068	Closed	-$2.1M	–	1362
2019 Q2	$2.1M	Sell	34,068 -1,995	-6%	-$121K	0.21%	137
2019 Q1	$2.3M	Sell	36,063 -3,216	-8%	-$184K	0.22%	127
2018 Q4	$2M	Buy	+39,279	New	+$1.99M	0.2%	157
2018 Q3	–	Sell	-32,421	Closed	-$1.57M	–	1329
2018 Q2	$1.57M	Buy	32,421 +7,350	+29%	+$343K	0.11%	292
2018 Q1	$1.17M	Sell	25,071 -21,165	-46%	-$919K	0.1%	268
2017 Q4	$1.74M	Sell	46,236 -67,101	-59%	-$2.46M	0.16%	184
2017 Q3	$4.13M	Buy	113,337 +59,142	+109%	+$2.26M	0.4%	53
2017 Q2	$2.14M	Sell	54,195 -54	-0.1%	-$1.97K	0.2%	135
2017 Q1	$1.7M	Buy	+54,249	New	+$1.7M	0.18%	142
2016 Q3	–	Sell	-153,729	Closed	-$5.11M	–	1146
2016 Q2	$5.11M	Buy	153,729 +138,492	+909%	+$4.74M	0.54%	41
2016 Q1	$448K	Sell	15,237 -35,025	-70%	-$966K	0.07%	334
2015 Q4	$1.32M	Buy	+50,262	New	+$1.31M	0.23%	123
2015 Q2	–	Sell	-61,506	Closed	-$1.46M	–	1190
2015 Q1	$1.46M	Buy	61,506 +26,244	+74%	+$589K	0.36%	65
2014 Q4	$748K	Sell	35,262 -19,080	-35%	-$383K	0.24%	119
2014 Q3	$925K	Buy	54,342 +51,450	+1,779%	+$812K	0.13%	244
2014 Q2	$41K	Sell	2,892 -53,208	-95%	-$721K	0.01%	967
2014 Q1	$693K	Buy	56,100 +54,300	+3,017%	+$627K	0.16%	178
2013 Q4	$19K	Buy	+1,800	New	+$20.3K	0.01%	801
2013 Q3	–	Sell	-1,200	Closed	-$13K	–	804
2013 Q2	$13K	Buy	+1,200	New	+$14.2K	0.01%	454

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Quantbot Technologies's EW Position: Q1 2026 in Review

Quantbot Technologies sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 18,720 shares — an estimated $1.6M sold.

Quantbot Technologies first reported a position in EW in Q2 2013 and held it in 35 quarters. The position peaked at $13.6M in Q3 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Quantbot Technologies reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Quantbot Technologies sold 18,720 Edwards Lifesciences shares in Q1 2026, an estimated $1.6M.
Quantbot Technologies first reported a position in Edwards Lifesciences in Q2 2013 and held it in 35 quarters.
Quantbot Technologies's Edwards Lifesciences position peaked at $13.6M in Q3 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.